RLMD: RELMADA THERAPEUTICS, INC. insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 0 sales totaling - in the last 180 days.
Activist and 5% holders
| Filed | What | Holder | Stake | Change | Filing |
|---|---|---|---|---|---|
| 2026-08-14 | 13G amendment | Squadron Master Fund LP | 7.00% | SEC | |
| 2026-07-29 | New 13G stake | BlackRock, Inc. | 7.00% | SEC |
Institutional ownership (Q2 2026)
126 institutions reported holding $687.71M of RELMADA THERAPEUTICS, INC. on Form 13F (103 the quarter before). 46 opened a new position and 23 sold out. Shares held by institutions: +18%.
| Largest holders | Shares | Value |
|---|---|---|
| Jupiter Topco LLC | 11,164,803 | $77.32M |
| BlackRock, Inc. | 7,426,780 | $51.39M |
| Squadron Capital Management LLC | 7,350,000 | $50.86M |
| Venrock Adviser, LLC | 6,844,305 | $47.36M |
| Spruce Street Capital LP | 6,391,328 | $44.23M |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 4,763,158 | $32.96M |
| VANGUARD CAPITAL MANAGEMENT LLC | 4,460,210 | $30.86M |
| Jones Hill Capital LP | 3,655,075 | $25.29M |
| ORBIMED ADVISORS LLC | 3,631,195 | $25.13M |
| STATE STREET CORP | 2,517,550 | $17.42M |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.